Clinical Trial Update: Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B [NA]

View source ↗

Summary

Clinical trial comparing pegylated interferon alpha-2b monotherapy versus combination therapy with entecavir for HBeAg-negative chronic hepatitis B; the current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Chulalongkorn University | Conditions: Chronic Hepatitis B | NA | Status: UNKNOWN